Cargando…
High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is a typical malignancy in a background of chronic inflammation. Th17 cells (a major source of IL-17) constitute crucial components of infiltrating inflammatory/immune cells in HCC and can amplify inflammatory response via binding to interleukin-17 receptor...
Autores principales: | Liao, Rui, Sun, Jian, Wu, Han, Yi, Yong, Wang, Jia-Xing, He, Hong-Wei, Cai, Xiao-Yan, Zhou, Jian, Cheng, Yun-Feng, Fan, Jia, Qiu, Shuang-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621615/ https://www.ncbi.nlm.nih.gov/pubmed/23305119 http://dx.doi.org/10.1186/1756-9966-32-3 |
Ejemplares similares
-
Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma
por: Liu, Jian, et al.
Publicado: (2018) -
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
por: Gu, Fang-Ming, et al.
Publicado: (2011) -
IL-17C/IL-17RE: Emergence of a Unique Axis in T(H)17 Biology
por: Nies, Jasper F., et al.
Publicado: (2020) -
Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014) -
Serum IL-17 & eotaxin levels in asthmatic patients with allergic rhinitis
por: Lv, Hong, et al.
Publicado: (2016)